251 related articles for article (PubMed ID: 16839406)
1. Association of drug-serum protein adducts and anti-drug antibodies in dogs with sulphonamide hypersensitivity: a naturally occurring model of idiosyncratic drug toxicity.
Lavergne SN; Danhof RS; Volkman EM; Trepanier LA
Clin Exp Allergy; 2006 Jul; 36(7):907-15. PubMed ID: 16839406
[TBL] [Abstract][Full Text] [Related]
2. Anti-myeloperoxidase and anti-cathepsin G antibodies in sulphonamide hypersensitivity.
Lavergne SN; Drescher NJ; Trepanier LA
Clin Exp Allergy; 2008 Jan; 38(1):199-207. PubMed ID: 17976219
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study.
Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA
Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433
[TBL] [Abstract][Full Text] [Related]
4. Sulfonamide-induced reactions in desensitized patients with AIDS--the role of covalent protein haptenation by sulfamethoxazole.
Gruchalla RS; Pesenko RD; Do TT; Skiest DJ
J Allergy Clin Immunol; 1998 Mar; 101(3):371-8. PubMed ID: 9525454
[TBL] [Abstract][Full Text] [Related]
5. Anti-platelet antibodies in a natural animal model of sulphonamide-associated thrombocytopaenia.
Lavergne SN; Trepanier LA
Platelets; 2007 Dec; 18(8):595-604. PubMed ID: 18041651
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of human T cells with sulfonamides and sulfonamide metabolites.
Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ
J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253
[TBL] [Abstract][Full Text] [Related]
7. The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat.
Gill HJ; Hough SJ; Naisbitt DJ; Maggs JL; Kitteringham NR; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 1997 Aug; 282(2):795-801. PubMed ID: 9262343
[TBL] [Abstract][Full Text] [Related]
8. Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
Reilly TP; MacArthur RD; Farrough MJ; Crane LR; Woster PM; Svensson CK
J Pharmacol Exp Ther; 1999 Dec; 291(3):1356-64. PubMed ID: 10565861
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.
Roychowdhury S; Vyas PM; Reilly TP; Gaspari AA; Svensson CK
J Pharmacol Exp Ther; 2005 Jul; 314(1):43-52. PubMed ID: 15784651
[TBL] [Abstract][Full Text] [Related]
10. Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis.
Lavergne SN; Whitaker P; Peckham D; Conway S; Park BK; Naisbitt DJ
Chem Res Toxicol; 2010 Jun; 23(6):1009-11. PubMed ID: 20481640
[TBL] [Abstract][Full Text] [Related]
11. Blunted humoral response to influenza vaccination in patients exposed to zidovudine plus trimethoprim-sulfamethoxazole.
Feola DJ; Garvy BA; Rapp RP; Thornton AC
Pharmacotherapy; 2007 Jul; 27(7):937-47. PubMed ID: 17594199
[TBL] [Abstract][Full Text] [Related]
12. Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo.
Cheng L; Stewart BJ; You Q; Petersen DR; Ware JA; Piccotti JR; Kawabata TT; Ju C
Mol Pharmacol; 2008 Jun; 73(6):1769-75. PubMed ID: 18334600
[TBL] [Abstract][Full Text] [Related]
13. The association of opportunistic infections with the occurrence of trimethoprim/sulfamethoxazole hypersensitivity in patients infected with human immunodeficiency virus.
Lehmann DF; Liu A; Newman N; Blair DC
J Clin Pharmacol; 1999 May; 39(5):533-7. PubMed ID: 10234602
[TBL] [Abstract][Full Text] [Related]
14. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection.
Cribb AE; Nuss CE; Alberts DW; Lamphere DB; Grant DM; Grossman SJ; Spielberg SP
Chem Res Toxicol; 1996 Mar; 9(2):500-7. PubMed ID: 8839055
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to co-trimoxazole (trimethoprim and/or sulfamethoxazole) related to the presence of the drug in a commercial low-ionic-strength solution.
Pham BN; Gien D; Bensaad F; Babinet J; Dubeaux I; Rouger P; Le Pennec PY
Transfusion; 2012 Apr; 52(4):844-8. PubMed ID: 21910740
[TBL] [Abstract][Full Text] [Related]
16. Sequential assessment of an antidrug antibody response in a patient with a systemic delayed-onset sulphonamide hypersensitivity syndrome reaction.
Bedard K; Smith S; Cribb A
Br J Dermatol; 2000 Feb; 142(2):253-8. PubMed ID: 10730757
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection.
Wong YY; Rakasz EG; Gasper DJ; Friedrich TC; Trepanier LA
Toxicology; 2016 Aug; 368-369():10-18. PubMed ID: 27565715
[TBL] [Abstract][Full Text] [Related]
18. Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides.
Elzagallaai AA; Sultan EA; Bend JR; Abuzgaia AM; Loubani E; Rieder MJ
J Clin Pharmacol; 2020 Mar; 60(3):409-421. PubMed ID: 31709574
[TBL] [Abstract][Full Text] [Related]
19. Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins.
Cribb AE; Pohl LR; Spielberg SP; Leeder JS
J Pharmacol Exp Ther; 1997 Aug; 282(2):1064-71. PubMed ID: 9262376
[TBL] [Abstract][Full Text] [Related]
20. Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: implications for hapten formation.
Callan HE; Jenkins RE; Maggs JL; Lavergne SN; Clarke SE; Naisbitt DJ; Park BK
Chem Res Toxicol; 2009 May; 22(5):937-48. PubMed ID: 19358516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
